Gallagher Carol Giltner

Average Profitability
129.11%
Insider Buys Quantity
4
Insider Buys Sum
$864,196.47
Insider Sells Quantity
18
Insider Sells Sum
$3.9M

Insider Activity of Gallagher Carol Giltner

According to the SEC Form 4 filings, Gallagher Carol Giltner, being in a position of

  1. director at Atara Biotherapeutics, Inc.,
    оver the last 12 months, has bought 270000 shares for $68,214, and sold 0 shares,
    over all time since 2014-10-21, has bought 328362 shares for $864,196, and sold 101424 shares for $3.9M.

The largest purchase of all time was on 2014-10-21 and amounted to 36362 shares of Atara Biotherapeutics, Inc. for $399,982.

The largest sale of all time was on 2018-11-07 and amounted to 21374 shares of Atara Biotherapeutics, Inc. for $777,586.

Biography of Gallagher Carol Giltner

No biography is available at this moment.

2023-11-14PurchaseAtara Biotherapeutics, Inc.
ATRA
director
90,980
0.0817%
$0.31$28,186+66.78%
2023-11-13PurchaseAtara Biotherapeutics, Inc.
ATRA
director
179,020
0.1541%
$0.22$40,029+125.43%
2018-11-07SaleAtara Biotherapeutics, Inc.
ATRA
director
21,374
0.0482%
$36.38$777,586-32.17%
2018-06-18SaleAtara Biotherapeutics, Inc.
ATRA
director
2,500
0.0056%
$44.78$111,944-17.17%
2018-05-16SaleAtara Biotherapeutics, Inc.
ATRA
director
273
0.0006%
$46.06$12,574-19.24%
2018-02-16SaleAtara Biotherapeutics, Inc.
ATRA
director
1,183
0.0031%
$46.50$55,010-13.18%
2017-11-16SaleAtara Biotherapeutics, Inc.
ATRA
director
1,184
0.0039%
$14.20$16,813+167.93%
2017-08-16SaleAtara Biotherapeutics, Inc.
ATRA
director
1,184
0.0039%
$14.30$16,931+156.1%
2017-06-09SaleAtara Biotherapeutics, Inc.
ATRA
director
1,000
0.0035%
$13.15$13,150+23.74%
2017-05-16SaleAtara Biotherapeutics, Inc.
ATRA
director
2,368
0.0081%
$15.25$36,112+1.15%
2017-02-16SaleAtara Biotherapeutics, Inc.
ATRA
director
2,366
0.0084%
$16.10$38,093-2.24%
2016-11-16SaleAtara Biotherapeutics, Inc.
ATRA
director
2,368
0.0086%
$19.35$45,821-17.7%
2016-05-18SaleAtara Biotherapeutics, Inc.
ATRA
director
2,368
0.008%
$15.96$37,793+12.62%
2016-02-17SaleAtara Biotherapeutics, Inc.
ATRA
director
2,366
0.0077%
$16.30$38,566+5.71%
2015-11-17SaleAtara Biotherapeutics, Inc.
ATRA
director
2,368
0.0092%
$31.10$73,645-36.2%
2015-08-24SaleAtara Biotherapeutics, Inc.
ATRA
director
11,748
0.0449%
$40.51$475,872-42.49%
2015-08-21SaleAtara Biotherapeutics, Inc.
ATRA
director
11,748
0.0421%
$41.71$490,030-47.58%
2015-08-20SaleAtara Biotherapeutics, Inc.
ATRA
director
11,748
0.0444%
$44.80$526,278-48.5%
2015-08-19SaleAtara Biotherapeutics, Inc.
ATRA
director
11,750
0.0435%
$48.18$566,165-53.13%
2015-08-18SaleAtara Biotherapeutics, Inc.
ATRA
director
11,528
0.0415%
$49.38$569,253-55.45%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.